MRI-guided thrombolysis for stroke with unknown time of onset G Thomalla, CZ Simonsen, F Boutitie, G Andersen, Y Berthezene, ... New England Journal of Medicine 379 (7), 611-622, 2018 | 1366 | 2018 |
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ... New England Journal of Medicine 359 (12), 1238-1251, 2008 | 1289 | 2008 |
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised … W Hacke, AJ Furlan, Y Al-Rawi, A Davalos, JB Fiebach, F Gruber, M Kaste, ... The Lancet Neurology 8 (2), 141-150, 2009 | 741 | 2009 |
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4· 5 h of symptom onset (PRE-FLAIR): a multicentre observational study G Thomalla, B Cheng, M Ebinger, Q Hao, T Tourdias, O Wu, JS Kim, ... The Lancet Neurology 10 (11), 978-986, 2011 | 694 | 2011 |
CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute … JB Fiebach, PD Schellinger, O Jansen, M Meyer, P Wilde, J Bender, ... Stroke 33 (9), 2206-2210, 2002 | 661 | 2002 |
Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging JB Fiebach, PD Schellinger, A Gass, T Kucinski, M Siebler, A Villringer, ... Stroke 35 (2), 502-506, 2004 | 660* | 2004 |
Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial M Ebinger, B Winter, M Wendt, JE Weber, C Waldschmidt, M Rozanski, ... Jama 311 (16), 1622-1631, 2014 | 538 | 2014 |
A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage PD Schellinger, O Jansen, JB Fiebach, W Hacke, K Sartor Stroke 30 (4), 765-768, 1999 | 523 | 1999 |
Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke< 6 hours J Rother, PD Schellinger, A Gass, M Siebler, A Villringer, JB Fiebach, ... Stroke 33 (10), 2438-2445, 2002 | 485 | 2002 |
Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with … P Schramm, PD Schellinger, E Klotz, K Kallenberg, JB Fiebach, ... Stroke 35 (7), 1652-1658, 2004 | 455 | 2004 |
Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status PD Schellinger, JB Fiebach, W Hacke Stroke 34 (2), 575-583, 2003 | 442 | 2003 |
Acute stroke imaging research roadmap M Wintermark, GW Albers, AV Alexandrov, JR Alger, R Bammer, JC Baron, ... Stroke 39 (5), 1621-1628, 2008 | 420 | 2008 |
Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study S Wegener, B Gottschalk, V Jovanovic, R Knab, JB Fiebach, ... Stroke 35 (3), 616-621, 2004 | 415 | 2004 |
Long-chain omega-3 fatty acids improve brain function and structure in older adults AV Witte, L Kerti, HM Hermannstädter, JB Fiebach, SJ Schreiber, ... Cerebral cortex 24 (11), 3059-3068, 2014 | 411 | 2014 |
Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? PD Schellinger, JB Fiebach, K Hoffmann, K Becker, B Orakcioglu, ... Stroke 34 (7), 1674-1679, 2003 | 346 | 2003 |
Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset P Schramm, PD Schellinger, JB Fiebach, S Heiland, O Jansen, M Knauth, ... Stroke 33 (10), 2426-2432, 2002 | 329 | 2002 |
Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the … G Thomalla, C Schwark, J Sobesky, E Bluhmki, JB Fiebach, J Fiehler, ... Stroke 37 (3), 852-858, 2006 | 328 | 2006 |
Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI O Jansen, P Schellinger, J Fiebach, W Hacke, K Sartor The Lancet 353 (9169), 2036-2037, 1999 | 317 | 1999 |
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials R Vandenberghe, JO Rinne, M Boada, S Katayama, P Scheltens, B Vellas, ... Alzheimer's research & therapy 8, 1-13, 2016 | 315 | 2016 |
MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study M Köhrmann, E Jüttler, JB Fiebach, HB Huttner, S Siebert, C Schwark, ... The Lancet Neurology 5 (8), 661-667, 2006 | 308 | 2006 |